- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarker of Neuroinflammation in Parkinson’s Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 8, Pages 4148
Publisher
MDPI AG
Online
2022-04-09
DOI
10.3390/ijms23084148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
- (2021) Xiao-yi Kuai et al. Microbial Cell Factories
- DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65
- (2021) Zixuan Lin et al. Cell Death & Disease
- Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF ‐α Pathway
- (2021) Chin‐Hsien Lin et al. MOVEMENT DISORDERS
- Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
- (2021) Yunna Li et al. Frontiers in Immunology
- NRF2 Activation Ameliorates Oxidative Stress and Improves Mitochondrial Function and Synaptic Plasticity, and in A53T α-Synuclein Hippocampal Neurons
- (2021) Mikah S. Brandes et al. Antioxidants
- Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice
- (2020) Collin Challis et al. NATURE NEUROSCIENCE
- Synucleinphagy: a microglial “community cleanup program” for neuroprotection
- (2020) Insup Choi et al. Autophagy
- Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology
- (2020) Laura C. Maclagan et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
- (2020) Insup Choi et al. Nature Communications
- Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia
- (2019) Nikhil Panicker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
- (2019) Chin-Hsien Lin et al. Journal of Neuroinflammation
- Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone
- (2019) Roberto Frau et al. NATURE NEUROSCIENCE
- LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
- (2019) Daniel C. Berwick et al. Molecular Neurodegeneration
- Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease
- (2018) Madelyn C. Houser et al. MOVEMENT DISORDERS
- Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
- (2018) Inga Peter et al. JAMA Neurology
- Oxidative stress and neuroinflammation in the story of Parkinson’s disease: Could targeting these pathways write a good ending?
- (2018) Kambiz Hassanzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis
- (2018) Tahmina Nasrin Poly et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
- (2018) Richard Gordon et al. Science Translational Medicine
- A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity
- (2017) Ethan Stolzenberg et al. Journal of Innate Immunity
- Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
- (2017) Paolo Eusebi et al. MOVEMENT DISORDERS
- Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
- (2017) Brit Mollenhauer et al. NEUROLOGY
- Genetic Forms of Parkinson's Disease
- (2017) Christine Kim et al. SEMINARS IN NEUROLOGY
- Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
- (2016) Isabel Lastres-Becker et al. ANTIOXIDANTS & REDOX SIGNALING
- Parkinson's disease: Autoimmunity and neuroinflammation
- (2016) Armando De Virgilio et al. AUTOIMMUNITY REVIEWS
- Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function
- (2016) Noemí Esteras et al. BIOLOGICAL CHEMISTRY
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
- (2016) Caroline H. Williams-Gray et al. MOVEMENT DISORDERS
- Ibuprofen or piroxicam protects nigral neurons and delays the development of l -dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis
- (2016) Asmaa M. Teema et al. NEUROPHARMACOLOGY
- DJ-1 mutation decreases astroglial release of inflammatory mediators
- (2016) A.K. Ashley et al. NEUROTOXICOLOGY
- Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
- (2016) Marcus M. Unger et al. PARKINSONISM & RELATED DISORDERS
- Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease
- (2016) Xiao-Yan Qin et al. JAMA Neurology
- Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
- (2015) João P. L. Daher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
- (2015) Erdinç Dursun et al. JOURNAL OF NEUROIMMUNOLOGY
- Microglia-Mediated Inflammation and Neurodegenerative Disease
- (2015) Ling Xu et al. MOLECULAR NEUROBIOLOGY
- Colonic bacterial composition in Parkinson's disease
- (2015) Ali Keshavarzian et al. MOVEMENT DISORDERS
- Mitochondrial DNA stress primes the antiviral innate immune response
- (2015) A. Phillip West et al. NATURE
- Parkinson disease with REM sleep behavior disorder: Features, -synuclein, and inflammation
- (2015) Y. Hu et al. NEUROLOGY
- The association between infectious burden and Parkinson's disease: A case-control study
- (2015) Xian-Le Bu et al. PARKINSONISM & RELATED DISORDERS
- Interleukin-6 May Contribute to Mortality in Parkinson’s Disease Patients: A 4-Year Prospective Study
- (2015) Michal Dufek et al. Parkinsons Disease
- Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease
- (2015) Yuko Koshimori et al. PLoS One
- Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
- (2015) Satoru Hasegawa et al. PLoS One
- Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
- (2014) Michael J. White et al. CELL
- Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
- (2014) Anthony Rongvaux et al. CELL
- Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis
- (2014) Liang Gao et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: Evidence from a meta-analysis
- (2014) Wataru Sako et al. MOVEMENT DISORDERS
- The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease
- (2014) Eşref Akıl et al. NEUROLOGICAL SCIENCES
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
- (2014) Peng Tang et al. Oxidative Medicine and Cellular Longevity
- MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
- (2014) Carolina Cebrián et al. Nature Communications
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- DJ-1 Associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes
- (2013) Kwang Soo Kim et al. HUMAN MOLECULAR GENETICS
- Is Neuroinflammation Involved in the Development of Dementia in Patients with Parkinson's Disease?
- (2013) In-Uk Song et al. INTERNAL MEDICINE
- DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline
- (2013) Dorit Trudler et al. JOURNAL OF NEUROCHEMISTRY
- Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease
- (2013) Natália Pessoa Rocha et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- Advances in the genetics of Parkinson disease
- (2013) Joanne Trinh et al. Nature Reviews Neurology
- Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
- (2013) Changyoun Kim et al. Nature Communications
- Parkinsonism Due to Mutations in PINK1, Parkin, and DJ-1 and Oxidative Stress and Mitochondrial Pathways
- (2013) M. R. Cookson Cold Spring Harbor Perspectives in Medicine
- PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices
- (2013) Jun Kim et al. Experimental Neurobiology
- Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson’s disease
- (2012) Gülnur Andican et al. ACTA NEUROLOGICA BELGICA
- Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients
- (2012) Dariusz Koziorowski et al. CYTOKINE
- Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
- (2012) Lisa Fellner et al. GLIA
- Interleukin-6, a Major Cytokine in the Central Nervous System
- (2012) María Erta et al. International Journal of Biological Sciences
- LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
- (2012) M. S. Moehle et al. JOURNAL OF NEUROSCIENCE
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Correlation between Protective Immunity to a-Synuclein Aggregates, Oxidative Stress and Inflammation
- (2012) Marina A. Gruden et al. NEUROIMMUNOMODULATION
- Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity
- (2012) F. Gillardon et al. NEUROSCIENCE
- Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease
- (2012) Ekaterina Yonova-Doing et al. PARKINSONISM & RELATED DISORDERS
- Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
- (2012) Daniel Lindqvist et al. PLoS One
- An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
- (2012) Philipp Mahlknecht et al. Proteome Science
- Meta-analysis of published studies identified eight additional common susceptibility loci for Crohnʼs disease and ulcerative colitis
- (2011) Junji Umeno et al. INFLAMMATORY BOWEL DISEASES
- Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
- (2011) Marina A. Gruden et al. JOURNAL OF NEUROIMMUNOLOGY
- The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
- (2011) Yvonne Couch et al. Journal of Neuroinflammation
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
- (2011) Christine R Swanson et al. Journal of Neuroinflammation
- Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson’s Disease
- (2011) Angelika D. Manthripragada et al. NEUROEPIDEMIOLOGY
- Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
- (2011) Dawn Béraud et al. PARKINSONISM & RELATED DISORDERS
- Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice
- (2011) Ravi S. Akundi et al. PLoS One
- α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
- (2011) Kiran Yanamandra et al. PLoS One
- Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B
- (2011) Thi A. Tran et al. PLoS One
- Short communication Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
- (2010) T. Müller et al. ACTA NEUROLOGICA SCANDINAVICA
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- -Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
- (2010) E.-J. Lee et al. JOURNAL OF IMMUNOLOGY
- Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease
- (2010) Ashley D. Reynolds et al. JOURNAL OF IMMUNOLOGY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
- (2010) Kiichi Nakahira et al. NATURE IMMUNOLOGY
- Correlation between FEPPA uptake and microglia activation in 6-OHDA injured rat brain
- (2010) Kentaro Hatano et al. NEUROIMAGE
- Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson’s disease
- (2010) In-Uk Song et al. NEUROLOGICAL SCIENCES
- Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
- (2010) Vanesa Sanchez-Guajardo et al. PLoS One
- Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin
- (2010) E. Ziviani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
- (2010) Derek P. Narendra et al. PLOS BIOLOGY
- Circulating interleukin-10 and interleukin-12 in Parkinson’s disease
- (2009) M. Rentzos et al. ACTA NEUROLOGICA SCANDINAVICA
- PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson’s disease
- (2009) Nicoletta Schintu et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Is There an Association between the Level of High-Sensitivity C-Reactive Protein and Idiopathic Parkinson’s Disease? A Comparison of Parkinson’s Disease Patients, Disease Controls and Healthy Individuals
- (2009) In-Uk Song et al. EUROPEAN NEUROLOGY
- Anti-melanin antibodies are increased in sera in Parkinson's disease
- (2009) K.L. Double et al. EXPERIMENTAL NEUROLOGY
- Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease
- (2009) Paula Scalzo et al. JOURNAL OF NEUROIMMUNOLOGY
- Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation
- (2009) Ana Laura De Lella Ezcurra et al. NEUROBIOLOGY OF DISEASE
- Interleukin-6 Serum Levels in Patients with Parkinson’s Disease
- (2009) Kerly Wollmeister Hofmann et al. NEUROCHEMICAL RESEARCH
- Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance
- (2009) Paula Scalzo et al. NEUROSCIENCE LETTERS
- Genomewide Association Study of Leprosy
- (2009) Fu-Ren Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peripheral cytokines profile in Parkinson’s disease
- (2008) M. Reale et al. BRAIN BEHAVIOR AND IMMUNITY
- PPAR: a therapeutic target in Parkinsons disease
- (2008) Rajnish K. Chaturvedi et al. JOURNAL OF NEUROCHEMISTRY
- Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
- (2008) Shaji Theodore et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
- (2008) T. C. Frank-Cannon et al. JOURNAL OF NEUROSCIENCE
- Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
- (2008) Bogdan Brodacki et al. NEUROSCIENCE LETTERS
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
- Glial reactions in Parkinson's disease
- (2007) Patrick L. McGeer et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation